An 11-amino-acid peptide (also called cibinetide) designed from erythropoietin, studied in small human trials in small-fiber neuropathy. Prescribed online after a licensed provider reviews your online visit, compounded by U.S. 503A pharmacies, and shipped discreetly to every state except Alabama, Arizona, Arkansas, California, Hawaii, Kentucky, Maryland, Massachusetts, Minnesota, Mississippi, Nebraska, North Carolina, Ohio, Oregon, South Carolina, South Dakota, Tennessee, Virginia and West Virginia.
$299
Choose your formula
Supply
One payment for a 3-month supply.
A few private questions, then a licensed provider reviews your answers.

The essentials
Erythropoietin-derived peptide
ARA-290, also known as cibinetide, is an 11-amino-acid peptide modelled on one part of erythropoietin (EPO), the hormone that drives red blood cell production. It was designed to act on what researchers call the innate repair receptor, which is linked to tissue protection and inflammation, without stimulating red blood cell production.
The human evidence is small and early. ARA-290 has been studied in small randomised pilot trials in people with small-fiber neuropathy, mostly linked to sarcoidosis, and in one small study in type 2 diabetes with neuropathic symptoms. It has not been shown to treat any condition in large trials, and it is not an FDA-approved medication.
This is a compounded preparation, not an FDA-approved medication, and compounded drugs are not reviewed by the FDA for safety or effectiveness. Individual results are not guaranteed. It is prescribed only where a licensed provider determines it is appropriate after reviewing your health history.
ARA-290 comes up because of small clinical studies in small-fiber neuropathy, where it was associated with changes in symptoms and in corneal nerve fibers. Those trials were small and short, and they do not establish a benefit for any other use.
Every ARA-290 prescription here follows a review by a licensed provider of your health history, current medications and goals. If it isn't appropriate for you, it isn't prescribed.
Your vial is compounded by a licensed U.S. 503A pharmacy and dispensed against a prescription written in your name, not sold as a "research only" product with no oversight.
The short answer: unregulated supplements make claims nobody checks, "research only" vials sold online carry no prescription, no pharmacy and no accountability, and a prescribed ARA-290 is compounded by a licensed 503A pharmacy against a provider's order written for you.
| Oral supplement | "Research only" vial | Prescribed ARA-290 (Rx) | |
|---|---|---|---|
| What it is | An unregulated oral product | A vial sold without a prescription | Compounded ARA-290 dispensed on a provider's order |
| Licensed provider reviews you | No | No | Yes, before anything is dispensed |
| Compounded by a licensed pharmacy | No | No | Yes, U.S. 503A |
| Your name on the vial | No | No | Yes |
| Dose set by a prescriber | No | No | Yes |
The simplest test of any peptide seller: is your name on the vial? A "research only" label means no prescriber reviewed you, no licensed pharmacy compounded it, and nobody is accountable for what is actually inside.
Three steps: answer a short set of medical questions, a licensed provider reviews them, and if they prescribe, a 503A pharmacy compounds and ships it.
A short private medical questionnaire about your history, current medications and what you are hoping to address. It takes a couple of minutes.
A provider licensed in your state reviews your answers online. No appointment, no waiting room. They decide whether ARA-290 is appropriate.
If they prescribe, a licensed U.S. 503A pharmacy compounds your vial and ships it discreetly, with your name on the label.
It's for adults who want ARA-290 prescribed and compounded properly rather than bought from a grey market. Whether it is appropriate for you is a decision for the provider who reviews your visit.
You have read about ARA-290 and want it prescribed rather than bought from an unregulated seller.
Reviewed by a licensed provider, compounded by a 503A pharmacy, dispensed with your name on the vial.
The amount and schedule are set by your prescriber, not selected here or taken from a forum.
ARA-290 is compounded as a subcutaneous injection.
ARA-290 has been tested only in small, short human studies, mainly in small-fiber neuropathy. It has not been shown to treat neuropathy or any other condition, and it is not a substitute for evaluation of numbness, burning or nerve pain by a clinician. It is a compounded preparation, not an FDA-approved medication, and compounded drugs are not reviewed by the FDA for safety or effectiveness. Individual results are not guaranteed. If you are pregnant or breastfeeding, have an active cancer diagnosis, or have significant kidney or liver disease, tell your provider in your answers. New or unexplained symptoms should be evaluated by a clinician rather than self-treated.
You answer a few questions, a licensed provider reviews your answers, and if they prescribe, your medication is compounded and shipped to your door. No insurance required, no in-person appointment, no waiting room.
Answer a short set of private medical questions. Add as many peptides as you like; one checkout, and a provider reviews each.
A provider licensed in your state reviews your answers online. Approval is never guaranteed.
If prescribed, your vial is compounded by a 503A pharmacy and ships in plain, unmarked packaging to every state except Alabama, Arizona, Arkansas, California, Hawaii, Kentucky, Maryland, Massachusetts, Minnesota, Mississippi, Nebraska, North Carolina, Ohio, Oregon, South Carolina, South Dakota, Tennessee, Virginia and West Virginia.
Your price is shown before you pay. No insurance needed.
ARA-290 is compounded as injection. The amount and the schedule are set by the provider who reviews your visit. We deliberately do not publish a dosing regimen here, because that is a clinical decision about you, not a product specification.
ARA-290 has been tested only in small, short human studies, mainly in small-fiber neuropathy. It has not been shown to treat neuropathy or any other condition, and it is not a substitute for evaluation of numbness, burning or nerve pain by a clinician. It is a compounded preparation, not an FDA-approved medication, and compounded drugs are not reviewed by the FDA for safety or effectiveness. Individual results are not guaranteed.
Reported effects are most often related to the injection itself. They can include:
Tell your provider about every condition and medication before starting, including pregnancy or breastfeeding. Stop and seek care for signs of an allergic reaction: rash, swelling of the face or throat, or difficulty breathing. For emergencies call 911.
A side-by-side look at the immune support options available through ForbiddenRx. Which one is appropriate for you is decided by the provider who reviews your visit.
| Treatment | What it is | Focus | Form | For | Rx required |
|---|---|---|---|---|---|
| ARA-290 This page | Erythropoietin-derived peptide | Immune category | Injection | Adults 18+ | Yes |
| LL-37 | Cathelicidin peptide | Immune category | Injection | Adults 18+ | Yes |
| Thymosin Alpha-1 | 28-amino-acid peptide | Immune category | Injection | Adults 18+ | Yes |
ARA-290 (cibinetide) is an 11-amino-acid peptide designed from erythropoietin to act on the innate repair receptor without stimulating red blood cell production.
No. It is modelled on one part of erythropoietin and was designed not to raise red blood cell counts. It is not EPO and does not act the same way.
Only in small, early trials, mostly in people with small-fiber neuropathy linked to sarcoidosis, plus one small study in type 2 diabetes. There are no large trials, and no benefit has been established.
No. It is a compounded preparation, not an FDA-approved medication, and compounded drugs are not reviewed by the FDA for safety or effectiveness. Individual results are not guaranteed.
No. You complete the questionnaire online and a licensed provider reviews it. There is no scheduling step and no waiting room.
Yes. Add each one to your cart and check out once. A provider reviews every treatment in your order.
Physicians, NPs & PAs licensed in your state
U.S.-based compounding partners
We confirm your state during intake
If you are going to take ARA-290, take one a licensed provider prescribed and a 503A pharmacy compounded with your name on it. Answer a few questions and a licensed provider reviews them.
Written by ForbiddenRx and checked against FDA prescribing information and published sources · Updated November 2026. It is general information, not a review of your own health; your provider decides what is right for you. It is provided for general educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always talk with a licensed provider about your individual health.
This page is educational and is not medical advice.
ARA-290
You can add up to 5 peptides to this same visit. Same questions, one checkout.